Hvorfor foretrækkes 8011 legering til farmaceutiske blisterpakker?
8011 offers superior formability with 25-30% elongation for deep-drawn cavities. Its high purity (99.3% Al) meets FDA 21 CFR requirements for drug contact. The alloy's Fe/Si composition prevents pinhole defects during foil rolling. It maintains barrier Egenskaber mod fugt og iltpermeation . Typisk tykkelse varierer fra 20-50 μm for optimal beskyttelse.
Hvordan sammenlignes 8011 med 8021 til blisteremballage?
8011 has 15% higher tensile strength (145MPa vs 125MPa in 8021) for better puncture resistance. Both alloys share similar corrosion resistance in pH 4-8 environments. 8011's slightly higher iron content improves heat seal consistency at 180-220℃. 8021 is preferred for ultratynd (<15μm) applications due to lower hardness. EU Pharmacopeia approves both for sterile packaging.
Hvilke overfladebehandlinger forbedrer 8011s farmaceutiske ydeevne?
Elektrokemisk polering reducerer overfladen ruhed til<0.8μm Ra for cleanability. Chromate-free passivation (e.g., TCPO) improves corrosion resistance. PVdC or acrylic lacquer coatings enable cold-form blister processing. Laser etching creates micro-textures for improved lidding adhesion. All treatments must pass ISO 10993-1 biocompatibility tests.
Hvad er de vigtigste kvalitetstest for 8011 blisterfolie?
Pinhole -inspektion kræver<3 defects/m² under 2000lx backlighting. Thickness tolerance must be ±5% across rolls. Residual solvents are limited to <2mg/m² per USP <661>{{0.
Hvordan understøtter 8011 bæredygtighed i pharma -emballage?
Its 100% recyclability aligns with WHO's AMR packaging guidelines. Foil production consumes 60% less energy than plastic alternatives. Lightweighting to 25μm reduces material use by 20% versus legacy 50μm. Post-consumer recycled content can reach 30% without performance loss. Lifecycle assessments show 45% lavere kulstofaftryk end flerlagsplastik .
